Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap EUR Fonds 35004490 / LU1540962211

123.60 EUR
-7.10 EUR
-5.43 %
15.11.2024
NAV

Nettoinventarwert (NAV)

123.60 EUR -7.10 EUR -5.43 %
Vortag 130.70 EUR Datum 15.11.2024

HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap EUR Fonds Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Stellar ETP CH1109575535 516.28%
21Shares Sui Staking ETP CH1360612159 311.75%
21Shares Cardano ETP CH1102728750 248.46%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Ripple XRP ETP CH0454664043 205.95%
21Shares The Sandbox ETP CH1177361008 156.86%
21Shares Injective Staking ETP CH1360612134 72.42%
21Shares Immutable ETP CH1360612142 48.68%
Name ISIN Performance
21Shares Stellar ETP CH1109575535 438.47%
21Shares Ripple XRP ETP CH0454664043 223.66%
21Shares Cardano ETP CH1102728750 164.97%
21Shares Stacks Staking ETP CH1258969042 145.10%
21Shares Aave ETP CH1135202120 129.28%
Name ISIN Performance
21Shares Stellar ETP CH1109575535 369.94%
21Shares Solana staking ETP CH1114873776 289.34%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 250.92%
21Shares Fantom ETP CH1168929078 224.48%
21Shares Cardano ETP CH1102728750 209.24%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 1’655.56%
21Shares Stellar ETP CH1109575535 525.50%
21Shares Bitcoin Core ETP CH1199067674 470.97%
21Shares Bitcoin ETP CH0454664001 456.56%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 403.82%

Fundamentaldaten

Valor 35004490
ISIN LU1540962211
Emittent HBM Partners
Aufgelegt in Luxembourg
Auflagedatum 24.01.2018
Kategorie Branchen: Andere Sektoren
Währung EUR
Volumen 19’101’316.35
Depotbank Pictet & Cie (Europe) S.A. (Luxembourg)
Geschäftsjahresende 31.12.
Berichtsstand 07.11.2024

Anlagepolitik

So investiert der HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap EUR Fonds: The investment objective of the Sub-Fund is to achieve long-term capital growth. The goal is to generate a value trend that exceeds the performance of the NASDAQ Biotechnology Index (the “Benchmark”). No guarantee can be given that the investment objective will be achieved.

ETP Performance: HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap EUR Fonds

Performance 1 Jahr
17.85
Performance 2 Jahre
6.79
Performance 3 Jahre
-5.90
Performance 5 Jahre
7.61
Performance 10 Jahre -